These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37896869)

  • 1. Expression of Toll-like Receptors on the Immune Cells in Patients with Common Variable Immune Deficiency after Different Schemes of Influenza Vaccination.
    Kostinova AM; Latysheva EA; Akhmatova NK; Vlasenko AE; Skhodova SA; Khromova EA; Linok AV; Poddubikov AA; Latysheva TV; Kostinov MP
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Post-Vaccination Cellular Immune Response in Patients with Common Variable Immune Deficiency.
    Kostinova AM; Latysheva EA; Kostinov MP; Akhmatova NK; Skhodova SA; Vlasenko AE; Cherdantsev AP; Soloveva IL; Khrapunova IA; Loktionova MN; Khromova EA; Poddubikov AA
    Vaccines (Basel); 2024 Jul; 12(8):. PubMed ID: 39203969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency.
    Kostinova AM; Akhmatova NK; Latysheva EA; Dagil YA; Klimova SV; Vlasenko AE; Khromova EA; Latysheva TV; Kostinov MP
    Front Immunol; 2020; 11():1876. PubMed ID: 32973775
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C
    Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).
    Mieves JF; Wittke K; Freitag H; Volk HD; Scheibenbogen C; Hanitsch LG
    Curr Allergy Asthma Rep; 2017 Oct; 17(11):78. PubMed ID: 28983790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preserved Cellular Immunity Upon Influenza Vaccination in Most Patients with Common Variable Immunodeficiency.
    Friedmann D; Goldacker S; Peter HH; Warnatz K
    J Allergy Clin Immunol Pract; 2020; 8(7):2332-2340.e5. PubMed ID: 32330665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the Role of Toll-like Receptors in the Immunopathogenesis of Selected Primary and Secondary Immunodeficiencies.
    Mertowska P; Smolak K; Mertowski S; Grywalska E
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
    Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
    Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
    Howard LM; Hoek KL; Goll JB; Samir P; Galassie A; Allos TM; Niu X; Gordy LE; Creech CB; Prasad N; Jensen TL; Hill H; Levy SE; Joyce S; Link AJ; Edwards KM
    PLoS One; 2017; 12(1):e0167488. PubMed ID: 28099485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
    Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
    Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
    de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Profile of Toll-like Receptor 2 (TLR2), TLR4 and Their Cytosolic Downstream Signaling Pathway in Common Variable Immunodeficiency (CVID) Patients.
    Sharifi L; Aghamohammadi A; Rezaei N; Yazdani R; Mahmoudi M; Amiri MM; Masoumi F; Bokaie S; Tavasolian P; Sanaei R; Moshiri M; Tavakolinia N; Alinia T; Azizi G; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):188-200. PubMed ID: 29757592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies.
    Vesikari T; Ramsey K; Pitisuttithum P; Capeding R; Heijnen E; Sawlwin D; Oberyé J; Zhang B; Smolenov I
    Vaccine; 2020 Dec; 38(51):8224-8231. PubMed ID: 33139136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effect of Bacillus firmus on the expression of cytokines and toll-like receptors in mouse nasopharynx-associated lymphoid tissue (NALT) after intranasal immunization with inactivated influenza virus type A.
    Zanvit P; Tichopád A; Havlíčková M; Novotná O; Jirkovská M; Kološtová K; Cechová D; Julák J; Sterzl I; Prokešová L
    Immunol Lett; 2010 Nov; 134(1):26-34. PubMed ID: 20709105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency.
    van Assen S; de Haan A; Holvast A; Horst G; Gorter L; Westra J; Kallenberg CG; Telgt DS; Palache AM; Giezeman KM; Bijl M
    Clin Immunol; 2011 Nov; 141(2):161-8. PubMed ID: 21889412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
    Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
    Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency.
    Gardulf A; Abolhassani H; Gustafson R; Eriksson LE; Hammarström L
    J Allergy Clin Immunol; 2018 Dec; 142(6):1922-1931.e2. PubMed ID: 29678747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.